|
Page 47 |
|||||
|
No. 151 |
|||
|
Authors : |
Preutthipan S, Herabutya Y. |
||
|
Title : |
Vaginal misoprostol for cervical priming before operative hysteroscopy: A randomized controlled trial. |
||
|
Source : |
Obstetrics and Gynecology. 96(6):890-4, 2000(Dec). |
||
|
Keywords : |
Misoprostol, Operative hysteroscopy, Cervical priming |
||
|
Abstract : |
Objective : To investigate the effectiveness of vaginal misoprostol for cervical priming before operative |
||
|
hysteroscopy and to assess the cervicouterine complications related to cervical dilatation and hystero- |
|||
|
scopic surgery in nulliparous women. Methods: One hundred fifty-two women with definite intrauterine |
|||
|
lesions were randomly assigned to receive either 200 mug vaginal misoprostol or placebo. Cervical |
|||
|
response and outcome and complications of opera-tive hysteroscopy were assessed. Results: Thirty-five |
|||
|
subjects were needed in each arm to detect a type I error of 0.01 with a power of 0.99. The mean cervical |
|||
|
dilatation estimated by Hegar dilator was significantly different between the treated group (7.3 +/- 0.7 mm) |
|||
|
and the control group (3.8 +/- 1.1 mm, P <.001). In the misoprostol group, 55 (75.3%) patients needed |
|||
|
cervical dilation, compared with 75 (94.9%, P =.001) in the placebo group. The median time of cervical |
|||
|
dilation to Hegar number 9 was significantly shorter in the treated group (40 seconds) compared with the |
|||
|
control group (120 seconds, P <.001). The mean operative time was significantly shorter in the treated |
|||
|
group (36.4 +/- 10.9 minutes) compared with the control group (45.9 +/- 14.2 minutes, P <.001). Cervical |
|||
|
tears occurred in nine (11.4%) patients in the control group and in one (1.4%, P =.018) in the misoprostol |
|||
|
group. Creation of a false tract was more common in the control group. Two uterine perforations occurred |
|||
|
in the placebo group. Conclusion: Vaginal misoprostol applied before operative hysteroscopy reduced the |
|||
|
need for cervical dilation, facilitated hysteroscopic surgery, and minimized cervical complications. |
|||
|
|
|||
|
|
|||
|
No. 152 |
|||
|
Authors : |
Preutthipan S, Linasmita V. |
||
|
Title : |
Reproductive outcome following hysteroscopic lysis of intrauterine adhesions: a result of 65 cases at Ramathibodi |
||
|
Hospital. |
|||
|
Source : |
Journal of the Medical Association of Thailand. 83(1):42-6, 2000(Jan). |
||
|
Keywords : |
Intrauterine adhesions, Hysteroscopic adhesiolysis, Reproductive outcome |
||
|
Abstract : |
We reported the reproductive outcome of 65 patients with varying degrees of IUAs who underwent |
||
|
hysteroscopic adhesiolysis between August 1994 and December 1996 at Ramathibodi Hospital. Of the |
|||
|
65 patients treated, 29 had mild adhesions, 26 had moderate adhesions, and 10 had severe adhesions. |
|||
|
Adhesions were lysed with hysteroscopic scissors in 25, with biopsy forceps through hysteroscope in 10, |
|||
|
with electrosurgery using a monopolar probe in 22 patients, and with resectoscope in 8 patients. The mean |
|||
|
duration of the procedure was 15 +/- 2.1 minutes. The mean follow-up was 12 +/- 1.4 months. Of the 44 |
|||
|
patients who originally presented with secondary amenorrhea, 40 (90.9%) have normal menses, 4 (9.1%) |
|||
|
have hypomenorrhea. Of the 6 patients who had hypomenorrhea, 5 (83.3%) have normal menses. Cyclic |
|||
|
abdominal pain disappeared after treatment in all patients. Of the 45 patients with IUAs and infertility, 16 |
|||
|
(35.6%) conceived. Two (20%) of the infertile patients with initially severe adhesions conceived. |
|||
|
Of the 5 patients with RPL treated, delivered a full term baby and the other delivered a premature baby at 29 |
|||
|
weeks of gestation. All 18 patients who delivered, had live births. Adhesion reformation was absent in |
|||
|
patients with initially mild and moderate adhesion but occurred in 2 out of 10 (20%) patients with severe |
|||
|
adhesions. These two patients initially suffered from secondary amenorrhea but reported hypomenorrhea |
|||
|
after surgery. Both of them had tuberculosis of the genital tract. There were no serious complications |
|||
|
occurring in all 65 procedures. All 65 patients were discharged a few hours after the operation. |
|||
|
|
|||
|
|
|||
|
No. 153 |
|||
|
Authors : |
Puavilai S, Kunavisarut S, Vatanasuk M, Timpatanapong P, Sriwong ST, Janwitayanujit S, Nantiruj K, |
||
|
Totemchokchyakarn K, Ruangkanchanasetr S. |
|||
|
Title : |
Ocular toxicity of chloroquine among Thai patients. |
||
|
Source : |
International Journal of Dermatology. 38(12):934-7, 1999(Dec). |
||
|
Keywords : |
Antimalarials, Dermatology |
||
|
Abstract : |
Background Chloroquine has been prescribed for the treatment of Various diseases. The most serious side- |
||
|
effect of chloroquine is retinopathy. The frequency of occurrence or retinopathy varies from 0.001 to |
|||
|
40% depending on the criteria used. The purpose of this study was to evaluate the incidence of ocular |
|||
|
toxicity from chloroquine treatment among Thai patients. Methods A retrospective study was carried |
|||
|
out in patients treated with chloroquine at Ramathibodi Hospital over the past 10 years (1987-1997). |
|||
|
Patients eligible for review were followed by ophthalmic examination by an ophthalmotogist for at least |
|||
|
6 months after starting treatment. Results One hundred and fifty-five patients were studied. Nineteen were |
|||
|
men and 136 were women. They ranged in age from 10 to 70 years. Most patients received 250 mg of |
|||
|
chloroquine per day. The duration of treatment varied from 6 months to 14 years, and the cumulative |
|||
|
dose of chloroquine ranged from 26 to 1771 g. Fourteen patients (9%) had only corneal deposition, while |
|||
|
22 (14.2%) developed retinopathy. There were no correlations between corneal deposits or retinopathy and |
|||
|
age, sex, duration of treatment, or cumulative dose of chloroquine. Conclusions The present study confirms |
|||
|
the finding reported by Mackenzie (Am J Med 1983; 75 (Suppl 1A): 40-45) that retinopathy is not related |
|||
|
to the duration of treatment and cumulative dose of chloroquine. Based on our finding that retinopathy can |
|||
|
be detected as early as 9 months after starting chloroquine therapy, we recommend routine ophthalmic |
|||
|
examination before treatment and every 6 months thereafter. |